Vepesid

In the US, Vepesid (etoposide systemic) is a member of the drug class mitotic inhibitors and is used to treat Cancer, Hodgkin's Lymphoma, Ovarian Cancer, Small Cell Lung Cancer and Testicular Cancer.

US matches:

• VePesid


• Vepesid Oral

UK matches:

• Vepesid Soft Capsules 50 mg and 100 mg (SPC)

Ingredient matches for Vepesid

Etoposide

Etoposide is reported as an ingredient of Vepesid in the following countries:

• Argentina


• Australia


• Austria


• Belgium


• Bosnia & Herzegowina


• Brazil


• Colombia


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Estonia


• Finland


• Georgia


• Germany


• Greece


• Hong Kong


• Hungary


• Ireland


• Italy


• Japan


• Lithuania


• Luxembourg


• Mexico


• Netherlands


• New Zealand


• Norway


• Philippines


• Poland


• Portugal


• Romania


• Russian Federation


• Serbia


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Taiwan


• Thailand


• Turkey


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.